These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 8497284

  • 1. Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
    Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA.
    N Engl J Med; 1993 Jun 17; 328(24):1740-6. PubMed ID: 8497284
    [Abstract] [Full Text] [Related]

  • 2. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL.
    N Engl J Med; 1999 Jan 07; 340(1):23-30. PubMed ID: 9878641
    [Abstract] [Full Text] [Related]

  • 3. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R.
    Ann Pharmacother; 2005 Jan 07; 39(1):39-44. PubMed ID: 15562142
    [Abstract] [Full Text] [Related]

  • 4. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A, Csiszér E, Gyurkovics K, Bartnicka MT, Sands D, Kapranov N, Varoli G, Monici Preti PA, Mazurek H.
    Paediatr Drugs; 2007 Jan 07; 9 Suppl 1():21-31. PubMed ID: 17536872
    [Abstract] [Full Text] [Related]

  • 5. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
    Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, Montgomery AB, Albers GM, Ramsey BW, Smith AL.
    J Infect Dis; 1999 May 07; 179(5):1190-6. PubMed ID: 10191222
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics.
    Ballmann M, Smyth A, Geller DE.
    Respir Med; 2011 Dec 07; 105 Suppl 2():S2-8. PubMed ID: 22208546
    [Abstract] [Full Text] [Related]

  • 7. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G, Antypkin YG, Miano A, Moretti P, Zanda M, Varoli G, Monici Preti PA, Aryayev NL.
    Paediatr Drugs; 2007 Dec 07; 9 Suppl 1():11-20. PubMed ID: 17536871
    [Abstract] [Full Text] [Related]

  • 8. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Gappa M, Steinkamp G, Tümmler B, von der Hardt H.
    Scand J Gastroenterol Suppl; 1988 Dec 07; 143():74-6. PubMed ID: 3164515
    [Abstract] [Full Text] [Related]

  • 9. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM, Waugh J, Noble S.
    Drugs; 2003 Dec 07; 63(22):2501-20. PubMed ID: 14609360
    [Abstract] [Full Text] [Related]

  • 10. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review.
    Ratjen F, Brockhaus F, Angyalosi G.
    J Cyst Fibros; 2009 Dec 07; 8(6):361-9. PubMed ID: 19747887
    [Abstract] [Full Text] [Related]

  • 11. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
    Dal Negro R, Micheletto C, Tognella S, Visconti M, Turati C.
    Adv Ther; 2008 Oct 07; 25(10):1019-30. PubMed ID: 18821068
    [Abstract] [Full Text] [Related]

  • 12. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
    Stelmach I, Korzeniewska A, Stelmach W.
    Respiration; 2008 Oct 07; 75(2):178-81. PubMed ID: 17435382
    [Abstract] [Full Text] [Related]

  • 13. Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial.
    Konstan MW, Geller DE, Minić P, Brockhaus F, Zhang J, Angyalosi G.
    Pediatr Pulmonol; 2011 Mar 07; 46(3):230-8. PubMed ID: 20963831
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis.
    Mazurek H, Chiron R, Kucerova T, Geidel C, Bolbas K, Chuchalin A, Blanco-Aparicio M, Santoro D, Varoli G, Zibellini M, Cicirello HG, Antipkin YG.
    Pediatr Pulmonol; 2014 Nov 07; 49(11):1076-89. PubMed ID: 24464974
    [Abstract] [Full Text] [Related]

  • 15. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.
    Ratjen F, Munck A, Kho P, Angyalosi G, ELITE Study Group.
    Thorax; 2010 Apr 07; 65(4):286-91. PubMed ID: 19996339
    [Abstract] [Full Text] [Related]

  • 16. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG, Gembitskaia TE.
    Ter Arkh; 2010 Apr 07; 82(8):76-8. PubMed ID: 20873251
    [Abstract] [Full Text] [Related]

  • 17. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O, Lehmann C, Madabushi R, Kumar V, Derendorf H, Welte T.
    J Antimicrob Chemother; 2006 Oct 07; 58(4):822-9. PubMed ID: 16885180
    [Abstract] [Full Text] [Related]

  • 18. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G, Schmitt-Grohe S, Döring G, Staab D, Pfründer D, Beck G, Schubert R, Zielen S.
    Respir Med; 2008 Nov 07; 102(11):1643-53. PubMed ID: 18701270
    [Abstract] [Full Text] [Related]

  • 19. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.
    Retsch-Bogart GZ, Burns JL, Otto KL, Liou TG, McCoy K, Oermann C, Gibson RL, AZLI Phase II Study Group.
    Pediatr Pulmonol; 2008 Jan 07; 43(1):47-58. PubMed ID: 18041081
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D, Grasemann C, Staab D, Wollmann H, Ratjen F, German Cystic Fibrosis Growth Hormone Study Group.
    Pediatrics; 2007 Jun 07; 119(6):e1230-8. PubMed ID: 17545356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.